Research & Development in the
Canton of Zug

Premier Research Group SA

Since 1997 · 1–10 empl.

Premier Research Group SA is a clinical research and consulting provider for the life sciences sector. The company supports the development of drugs, medical devices, and diagnostics through services in study design, clinical development, regulatory strategy, and technology.

Furrer Hypertech

Since 2000 · 1–10 empl.

The core activity of Furrer Hypertech is electronics development, particularly the development and manufacture of specific electronic products and solutions, such as fans, simulators, test equipment, display devices and transmitters.

Corza Device GmbH

Since 2001 · 1–10 empl.

Corza Device GmbH develops and distributes surgical solutions for a range of medical specialties. The company offers products and services in biosurgery, biomedical textiles, ophthalmology, and wound closure.

BJH - Natur- und Resonanzforschung AG

Since 2003 · 1–10 empl.

BJH Europe is engaged in the development, manufacture and distribution of health products, particularly dietary supplements, care products and cosmetics based on natural ingredients, which are intended to support human health and well-being. The company's core activity lies in the research, development and marketing of products that promote and strengthen the health of the heart, brain, gut, skin and other areas of the body.

Limmat Scientific AG

Since 2005 · 1–10 empl.

The core activity of Limmat Scientific is the development and provision of engineering services and measurement technologies for the aerospace, power generation, automotive, medical and process engineering industries. In particular, the company focuses on the development of precise and fast aerodynamic probe measurement technologies, including the manufacture of five-hole probes, FRAP probes (Fast-Response Aerodynamic Probes) and wireless measurement systems.

FMT Fluid Management Technologies Swiss AG

Since 2006 · 1–10 empl.

The core activity of FMT Swiss AG is the development, manufacture and distribution of solutions for fluid management technology, particularly in the field of lubrication and hydraulic technology. This includes products such as diesel and heating oil systems, urea/AdBlue systems, central lubrication systems and hydraulic hoses. The company also offers services such as consulting, service and maintenance.

Novelpharm AG

Since 2006 · 1–10 empl.

The core activity of Novelpharm is the research and development of products based on natural solutions for diseases, as well as the marketing and distribution of these products.

Lowalt Technologies AG

Since 2006 · 1–10 empl.

Lowalt Technologies AG develops and supplies hardware, software and data systems for the low‑altitude economy, including a Drone Mothership System with modular smart racks and AI‑enabled drone swarms. The company provides strategy, deployment, operations and data‑analysis services for use cases such as smart cities, logistics, energy, maritime, defense and disaster relief.

Rapid Pharma Development GmbH

Since 2007 · 1–10 empl.

The core activity of Rapid Pharma Development GmbH is the provision of services for the development of pharmaceutical projects, particularly in the areas of: project management, CMC (Chemistry, Manufacturing and Controls), GMP auditing, regulatory consulting, development of active pharmaceutical ingredients (API) and formulations, analytical activities, and outsourcing management of pharmaceutical development projects. The company supports its customers in the development of medicinal products, from the early phase to market authorization, and offers a wide range of services to accelerate and optimize the development of pharmaceutical projects.

Sanoviva AG

Since 2007 · 11–20 empl.

The core activity of SanoViva is the development and research of sustainable products and technologies for the health of soils, plants, animals and humans. This includes the development of recipes and products from natural, organic and mineral raw materials, as well as the granting of licenses for the marketing of these products to partner companies.

Alexion Pharma GmbH

Since 2007 · 21–50 empl.

The core activity of Alexion is the development and provision of life-changing therapies for people with rare diseases. The company focuses on researching, developing and delivering medicines tailored to the needs of patients with rare diseases, and strives to improve the quality of life of these individuals.

Swiss Cardio Technologies AG

Since 2008 · 11–20 empl.

Swiss Cardio Technologies AG develops and licenses Cardioplexol®, a standardized ultra‑low‑volume cardioplegic solution for use in cardiovascular surgery. The company is the exclusive global license holder for Cardioplexol®, which has marketing approvals in 10 EU countries and Switzerland and is marketed through regional partners.

Olympic Therapeutics AG

Since 2008 · 1–10 empl.

Olympic Therapeutics AG develops bacteriophages for the treatment of MRSA and other bacterial infections, focusing on research and development of therapeutic phage candidates. The company’s activities include identification and development of phage candidates, intellectual property protection, and preparation for clinical development and commercialization.

Meditrial Europe AG

Since 2009 · 11–20 empl.

The core activity of Meditrial is the conduct of clinical trials and the provision of services for medical research, particularly for the MedTech, Pharma and Biotech industries. This includes, among other things, the planning and conduct of clinical trials, regulatory consulting, market access strategy and the provision of digital solutions for clinical research. Meditrial also acts as a representative for companies in various countries and offers services such as data management, risk assessment and emergency plans.

ACSANA AG

Since 2009 · 1–10 empl.

ACSANA AG develops vegan soft capsules from native tapioca starch that are free of carrageenan, GMOs and common allergens. The company holds patents for the technology in Europe, North America and Asia and offers licensing or sale of the technology to manufacturers and investors.

RS DYNAMICS GmbH

Since 2010 · 1–10 empl.

The core activity of RS DYNAMICS is the development and manufacture of specialized devices and technologies for various application areas, in particular: 1. Security: Explosive and drug detection devices, as well as combination devices for the detection of explosives and radioactive materials. 2. Earth Sciences: Technology and instruments for mapping and monitoring soil and groundwater pollution. 3. Medical Technology: Devices for the early detection of cancer, particularly breast cancer, as well as instruments to support researchers in medical technology. The company also offers customer-specific solutions and services in these areas.

Grosso Link GmbH

Since 2013 · 1–10 empl.

Grosso Link GmbH is a technology company focused on consumer electronics, intelligent manufacturing and smart transportation. It develops magnetic sensors (Hall and TMR), chip-level temperature sensors, zero-drift operational amplifiers, high-precision AD/DA converters and sensor-signal SoC solutions, and performs GNSS algorithm research and related design services.

Sofistiq International AG

Since 2013 · 11–20 empl.

The core activity of sofistiq International AG is the development and provision of high-quality software tools for market, brand, company, culture, leadership and personality analyses. The company offers a range of specific tools, such as culture:code, touch:point, smart:360°, rep:grid and cube, which enable customers to analyze and visualize complex data. The software solutions are tailored to the needs of companies and organizations that require a deeper understanding of their target groups and their own corporate culture.

AssesSurgery GmbH

Since 2013 · 1–10 empl.

AssesSurgery GmbH is a web-based service supporting surgeons and researchers interested in surgical quality improvement. It provides postoperative complication grading (Clavien‑Dindo), tools to assess overall morbidity, cost-prediction calculators, and the BAR score for liver transplantation risk matching. The platform offers online calculators and individual assistance for using and managing these tools and operates as an independent non‑profit organization.

Melzer GmbH

Since 2013 · 1–10 empl.

Melzer GmbH provides freelance engineering and development services in electronics, embedded systems, mechatronics, and control systems. Its core activities include hardware R&D, signal processing, motor control, optical design, and the analysis and development of sensor systems.

CRISPR Therapeutics AG

Since 2013 · 101–500 empl.

The core activity of CRISPR Therapeutics is the development of gene therapeutic medicines, particularly through the application of CRISPR-Cas9 technology, to cure diseases at the molecular level. The company focuses on developing medicines for various diseases such as sickle cell anemia, β-thalassemia, cancer, autoimmune disorders, and regenerative medicine.

DAMIAN PHARMA AG

Since 2014 · 1–10 empl.

The core activity of DAMIAN PHARMA AG is the development and marketing of pharmaceutical products, in particular the development of therapies for rare diseases such as Primary Aldosteronism (PA).

1abtik ag

Since 2015 · 1–10 empl.

The core activity of 1abtik is the application of bio-chemical molecules for health purposes, particularly through the provision of knowledge and networking in the field of Life Sciences.

Helvatron AG

Since 2015 · 11–20 empl.

The core activity of Helvatron AG is the development and provision of energy management software and hardware for measuring, monitoring and optimizing energy consumption. The company offers a comprehensive range of products and services, including intelligent energy meters, energy measuring devices, automation solutions and web-based software for evaluating and visualizing energy consumption data. The solutions are designed to support companies in the sustainable use of electrical energy and improve energy efficiency.

Alnylam Switzerland GmbH

Since 2015 · 21–50 empl.

The company is a pharmaceutical or biotechnology company specializing in the development and manufacture of medicines for rare diseases. The core activity includes research and development of RNAi-based therapies, the manufacture and marketing of medicines, as well as the provision of patient services, including genetic counseling and patient advocacy.

Rede Optimus Hospitalar AG

Since 2016 · 11–20 empl.

Rede Optimus is a Contract Research Organization (CRO) specializing in clinical trials and research in the field of medicine. The company's core activities include: conducting clinical trials for the medical industry, regulatory affairs and reimbursement support, medical writing and publication of study results, post-marketing clinical follow-up (PMCF) studies, investigator-initiated research and collaborative research with industry, and support for the approval of medical devices and obtaining CE markings and FDA approvals. The company also offers services such as electronic data capture (EDC), programming, and case report forms (CRFs), and has a network of highly qualified medical centers and experienced medical professionals.

BIONOVATICS AG

Since 2016 · 1–10 empl.

BIONOVATICS AG develops microbiological preparations for plant protection and nutrition. The company operates research and development laboratories and production facilities and supplies biological fungicides, bioinsecticides, microbial fertilizers and plant growth regulators.

KEYONIQ Health AG

Since 2016 · 1–10 empl.

KEYONIQ Health AG develops personalised health analytics and services that translate clinical and biomarker data into evidence-based action plans for healthier, longer lives. The company combines research, clinical expertise, large biomarker datasets and AI (InsightQore™; Biological Age Clock) to provide tailored recommendations on medications, supplements, nutrition, exercise, wellbeing and treatments.

Extrovis AG

Since 2016 · 101–500 empl.

Extrovis AG is a global Contract Research, Development & Manufacturing Organization (CRDMO) that develops and manufactures complex specialty therapeutics, including sterile antibiotics, oncology and cytotoxic formulations, and female hormone products. The company provides R&D, regulated-market manufacturing (USFDA, EU‑GMP) and supply‑chain and regulatory support across drug substances and finished dosage forms.

Sarepta International Holdings GmbH

Since 2017 · 1–10 empl.

The core activity of Sarepta Therapeutics is the development and manufacturing of gene therapies for the treatment of rare diseases, particularly muscular dystrophies such as Duchenne muscular dystrophy, limb-girdle muscular dystrophy (LGMD), and Charcot-Marie-Tooth disease. The company focuses on researching and developing precision gene medicine and aims to increase efficiency in drug development and shorten the time from laboratory to patient.

Web 3.0 Technologies Stiftung

Since 2017 · 21–50 empl.

The core activity of Web3 Foundation is to promote and support research and development of decentralized web software protocols, particularly in the area of blockchain technologies, with the goal of creating a decentralized and fair internet where users have control over their own data, identity and destiny.

Tele Radio Schweiz GmbH

Since 2017 · 1–10 empl.

Tele Radio Schweiz GmbH is a distributor of Tele Radio that supplies wireless radio remote-control systems, including transmitters, receivers and accessories for industrial, lifting and mobile-hydraulic applications. It provides sales, technical support, service and spare-parts for remote-control solutions.

Zinzino IP AG

Since 2017 · 1–10 empl.

Zinzino IP AG offers nutritional supplements, skincare products and home health tests under the Zinzino brand. Its range includes omega supplements, health tests and products for immune support, gut health, skin nutrition and weight management.

Aphaia Pharma AG

Since 2018 · 21–50 empl.

The core activity of Aphaia Pharma AG is the development and marketing of pharmaceuticals, particularly in the fields of life sciences and biotechnology. The company focuses on the research and development of innovative therapeutics and medications, particularly in the areas of microvascular medicine and the treatment of diseases such as obesity and metabolic disorders.

LifeScan Europe GmbH

Since 2018 · 1–10 empl.

LifeScan Europe GmbH develops and markets products and digital solutions for diabetes management. Its portfolio includes blood glucose meters, test strips, lancets, integrated digital health platforms, and hospital point-of-care systems.

Global Power and Propulsion Society

Since 2018 · 11–20 empl.

Global Power and Propulsion Society is a volunteer-led international community and forum for turbomachinery professionals and engineers in industry and academia. The society organises conferences, workshops and training, publishes conference proceedings and a journal, and provides datasets and viewpoint articles to support technical exchange and dissemination of research.

Apellis International GmbH

Since 2019 · 11–20 empl.

Apellis International GmbH develops medicines that inhibit the complement cascade by targeting the central protein C3. Its products include the C3‑targeting medicines EMPAVELI® and SYFOVRE®, and the company advances clinical and preclinical programs across ophthalmology, hematology, nephrology and gene-/RNA‑based therapeutic approaches.

Intellitraps GmbH

Since 2019 · 11–20 empl.

The core activity of Intellitraps Ltd. is the development and manufacture of camera trap systems for wildlife photography and environmental monitoring.